Dollard-des-Ormeaux, Canada

Yun-Xing Cheng

This inventor holds 1 USPTO granted patent. Top assignee: Biochem Pharma Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun-Xing Cheng. Retrieved from https://idiyas.com/inventor/yun-xing-cheng-uuspftce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yun-Xing Cheng in Flavivirus Treatment

Introduction

Yun-Xing Cheng is a notable inventor based in Dollard-des-Ormeaux, Canada. He has made significant contributions to the field of medical science, particularly in the treatment of viral infections. His innovative approach focuses on utilizing nucleoside analogues to combat flavivirus infections.

Latest Patents

Yun-Xing Cheng holds a patent for a method aimed at the treatment or prevention of flavivirus infections using nucleoside analogues. The patent describes a method that involves administering a therapeutically effective amount of a compound having a specific formula or a pharmaceutically acceptable salt thereof. This invention represents a promising advancement in the fight against flavivirus-related diseases.

Career Highlights

Cheng is associated with Biochem Pharma Inc., where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing therapeutic options for viral infections, showcasing his commitment to improving public health.

Collaborations

Some of his notable coworkers include Hicham Moulay Alaoui Ismaili and Jean-François Lavallée. Their collaborative efforts contribute to the innovative environment at Biochem Pharma Inc., fostering advancements in medical research.

Conclusion

Yun-Xing Cheng's contributions to the field of flavivirus treatment through his patented methods highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic strategies against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…